Optimization on biodistribution and antitumor activity of tripterine using polymeric nanoparticles through RES saturation

References

• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48.
   PubMed Web of Science ®Google Scholar
• Aoyama M, Hata K, Higashisaka K, et al. (2016). Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes. Biochem Biophys Res Commun 480:690–5.
   PubMed Web of Science ®Google Scholar
• Bi Y, Hao F, Yan G, et al. (2016). Actively targeted nanoparticles for drug delivery to tumor. Curr Drug Metab 17:763–82.
   PubMed Web of Science ®Google Scholar
• Chen Z, Tai Z, Gu F, et al. (2016). Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy. Eur J Pharm Biopharm 107:130–41.
   PubMed Web of Science ®Google Scholar
• Fornaguera C, Dols-Perez A, Caldero G, et al. (2015). PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier. J Control Release 211:134–43.
   PubMed Web of Science ®Google Scholar
• Grinberg S, Linder C, Heldman E. (2014). Progress in lipid-based nanoparticles for cancer therapy. Crit Rev Oncog 19:247–60.
   PubMedGoogle Scholar
• Guo J, Mei Y, Li K, et al. (2016). Downregulation of miR-17-92a cluster promotes autophagy induction in response to celastrol treatment in prostate cancer cells. Biochem Biophys Res Commun 478:804–10.
   PubMed Web of Science ®Google Scholar
• Gupta S. (2011). Biocompatible microemulsion systems for drug encapsulation and delivery. Curr Sci 101:174–88.
   Web of Science ®Google Scholar
• Huynh NT, Morille M, Bejaud J, et al. (2011). Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect. Pharm Res 28:3189–98.
   PubMed Web of Science ®Google Scholar
• Ishak KA, Annuar MSM, Ahmad N. (2017). Optimization of water/oil/surfactant system for preparation of medium-chain-length poly-3-hydroxyalkanoates (mcl-PHA)-incorporated nanoparticles via nanoemulsion templating technique. Appl Biochem Biotechnol 183:1191-1208.
   PubMed Web of Science ®Google Scholar
• Ji P, Yu T, Liu Y, et al. (2016). Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug Des Dev Ther 10:911–25.
   PubMed Web of Science ®Google Scholar
• Li S, Feng S, Ding L, et al. (2016). Nanomedicine engulfed by macrophages for targeted tumor therapy. Int J Nanomedicine 11:4107–24.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang T, Ye Y, et al. (2015). Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material. Int J Pharm 495:948–55.
   PubMed Web of Science ®Google Scholar
• Li Z, Wu X, Li J, et al. (2012). Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model. Int J Nanomedicine 7:2389–98.
   PubMed Web of Science ®Google Scholar
• Lu R, Liu S, Wang Q, Li X. (2015). Nanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement. Int J Nanomedicine 10:4937–46.
   PubMed Web of Science ®Google Scholar
• Lu Y, Park K. (2013). Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm 453:198–214.
   PubMed Web of Science ®Google Scholar
• Lucas AT, Herity LB, Kornblum ZA, et al. (2017). Pharmacokinetic and screening studies of the interaction between mononuclear phagocyte system and nanoparticle formulations and colloid forming drugs. Int J Pharm 526:443–54.
   PubMed Web of Science ®Google Scholar
• Margulis-Goshen K, Kesselman E, Danino D, Magdassi S. (2010). Formation of celecoxib nanoparticles from volatile microemulsions. Int J Pharm 393:230–7.
   PubMed Web of Science ®Google Scholar
• Mattheolabakis G, Rigas B, Constantinides PP. (2012). Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. Nanomedicine 7:1577–90.
   PubMed Web of Science ®Google Scholar
• Mi C, Shi H, Ma J, et al. (2014). Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9. Oncol Rep 32:2527–32.
   PubMed Web of Science ®Google Scholar
• Proffitt RT, Williams LE, Presant CA, et al. (1983). Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. Science 220:502–5.
   PubMed Web of Science ®Google Scholar
• Sanna V, Chamcheu JC, Pala N, et al. (2015). Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment. Int J Nanomedicine 10:6835–46.
   PubMed Web of Science ®Google Scholar
• Wang GZ, Liu YQ, Cheng X, Zhou GB. (2015). Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents. Cancer Sci 106:902–8.
   PubMed Web of Science ®Google Scholar
• Williams HD, Trevaskis NL, Charman SA, et al. (2013). Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65:315–499.
   PubMed Web of Science ®Google Scholar
• Xu S, Olenyuk BZ, Okamoto CT, Hamm-Alvarez SF. (2013). Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv Drug Del Rev 65:121–38.
   PubMed Web of Science ®Google Scholar
• Ye Y, Zhang X, Zhang T, et al. (2015). Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique. Drug Dev Ind Pharm 41:1416–24.
   PubMed Web of Science ®Google Scholar
• Zhang D, Kong YY, Sun JH, et al. (2017). Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance. IJN 12:2081–108.
   Web of Science ®Google Scholar
• Zhang X, Qi J, Lu Y, et al. (2014a). Biotinylated liposomes as potential carriers for the oral delivery of insulin. Nanomedicine 10:167–76.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang T, Zhou X, et al. (2014b). Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation. J Pharm Sci 103:1711–19.
   PubMed Web of Science ®Google Scholar
• Zhao K, Li D, Shi C, et al. (2016). Biodegradable polymeric nanoparticles as the delivery carrier for drug. CDD 13:494–9.
   PubMed Web of Science ®Google Scholar